Signaling pathways
-
BA7696 FABP-IN-2Summary: FABP-IN-2 is a novel ligand. - BA7697 FaX-IN-1Summary: FaX-IN-1 is an intermediate in the preparation of inhibitors.
- BA7698 AsundexianSummary: Asundexian (BAY2433334) is an orally active clotting factor inhibitor.
- BA7699 MilvexianSummary: Milvexian is an orally effective, small-molecule, reversible, direct-binding antagonist with values of 0.11, 0.38, 0.64, 490, and 350 nM in humans, rabbits, dogs, rats, and mice, respectively.
- BA7700 BMS-262084Summary: BMS-262084 is a potent, selective and irreversible inhibitor.
- BA7701 CiraparantagSummary: Ciraparantag is an inhibitor.
- BA7702 DarexabanSummary: Darexaban (YM150) is a potent, selective and orally active factor Xa inhibitor.
- BA7703 BMS-962212Summary: BMS-962212 is a direct, reversible, selective inhibitor.
- BA7704 FrunexianSummary: Frunexian (EP-7041) is a selective and potent inhibitor of coagulation factor XI/activating factor XI, targeting FactorXIa.
- BA7705 ZifaxabanSummary: Zifaxaban is an orally active, competitive and selective factor Xa inhibitor.